Consistent with the progressive nature of AD, the pro-excitatory eE/I ratio in the TCx was positively correlated with higher levels of AD biomarkers (tau, Braak stage, APP, and CERAD score) and with cognitive impairment. The gene discussed is MAPT; the disease is Cognitive impairment.